Literatur
-
1
Cookson W O.
The immunogenetics of asthma and eczema; a new focus on the epithelium.
Nav Rev Immunol.
2004;
4
978-988
-
2
Liu X.
Association between total serum IgE levels and the 6 potentially functional variants within the genes IL-4, IL-13, and IL4RA in German children. The German Multicenter Atopy Study.
J Allergy Clin Immunol.
2003;
112
382-388
-
3
Lee Y A, Wahn U, Kehrt R, Tarani L. et al .
A major susceptibility locus for atopic deramtitis maps to chromosom 3q21.
Nat Genet.
2000;
26
470-473
-
4
Kato A.
Association of SPINK5 gene polymorphism with atopic dermatitis in Japanese population.
Br J Dermatol.
2003;
148
665-669
-
5
Palmer C N, Irvine A D, Terron-Kwiatkowski A. et al .
Common-loss of function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis.
Nat Genet.
2006;
38
441-446
-
6
Hudson T J.
Skin barrier function and allergic risk.
Nat Genet.
2006;
38
399-400
-
7
Yoo J, Omori M, Gyarmati D. et al .
Spontaneous atopic dermatitis in mice expressing an inducile thymic stromal lymphopoetin transgene specifically in the skin.
J Exp Med.
2005;
202
541-549
-
8
Raap U, Goltz C, Deneka N. et al .
Brain derived neurotrophic factor is increased in atopic eczema and modulates eosinophil functions compared with that seen in non atopic subjects.
J Allergy Clin Immunol.
2005;
115
1268-1275
-
9
Hijnen D, Nijhuis E, bruin-Weller M. et al .
Differential expression of genes involved in skin homing, proliferation and apoptosis in CD4+gdas-T-cells of patients with atopic dermatitis.
J Invest Dermatol.
2005;
125
1149-1155
-
10
Kimata H.
Enhancement of allergic skin wheal responses and in vitro allergen-specific IgE production by computer-induced stress in patients with atopic dermatitis.
Brain Behav Immun.
2003;
17
134-138
-
11 Höger P. Kinderdermatologie. Stuttgart; Schattauer 2005: Kap. 19: Ekzeme, S. 144-173
-
12
Fölster-Holst R, Weichenthal M, Steinsland K, Polzhofer G, Christophers E.
Eczema infantum and its prognosis.
Acta Derm Venereol.
2004;
84
410-412
-
13
Illi S, von Mutius E, Lau S, Nickel R, Grüber C, Niggemann B, Wahn U.
The natural course of atopic dermatitis from birth to age 7 years and the association with asthma.
J Allergy Clin Immunol.
2004;
113
925-931
-
14
Celik-Bilgil S, Mehl A, Verstege A. et al .
The predictive value of specific immunoglobulin E levels in serum for the outcome of oral food challenges.
Clin Exp Allergy.
2005;
35
268-273
-
15
Leung D Y, Boguniewicz M, Howell M D, Nomura I, Hamid Q A.
New insights into atopic dermatitis.
J Clin Invest.
2004;
113
651-657
-
16
Darsow U, Laifaoui J, Kerschenlohr K. et al .
The prevalence of positive reactions in atopy patch test with aeroallergens and food allergens in subjeczs with atopic eczema. A European multicenter study.
Allergy.
2004;
59
1318-1325
-
17
Williams H C, Burney P G, Hay R J. et al .
The U.K. working party’s diagnostic criteria for atopic dermatitis. I. Derivation of a minimum set of discriminaters for atopic dermatitis.
Br J Dermatol.
1994;
131
383-396
-
18
Niggemann B. et al .
Standardisierung von oralen Provokationstests bei Nahrungsmittelallergien.
Allergo J.
2006;
15
262-270
-
19
Leifermann K M, Schroeter A, Kirschner M K, Spelsberg T C.
Characterization of the glucocorticoid receptor in human skin.
J Invest Dermatol.
1983;
81
355
-
20
Ashworth .
Quelle bei den Autoren.
.
;
-
21
Hanifin J, Gupta A K, Rajagopalan R.
Intermittend dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients.
Br J Dermatol.
2002;
147
528-537
-
22
Nuutinen P, Riekki R, Parikka M, Salo T, Autio P, Ristelli J, Oikarinen A.
Modulation of collagen synthesis and mRNA by continuous and intermittend use of topical hydrocortisone in human skin.
Br J Dermatol.
2003;
148
39-45
-
23
Gemeinsamer Bundesausschuss .
Therapiehinweis nach Nr. 14 der Arzneimittelrichtlinien. Pimecrolimus zur topischen Behandlung.
Dtsch Ärztebl.
2004;
101
A601-A603
-
24
Gemeinsamer Bundeausschuss .
Therapiehinweis nach Nr. 14 der Arzneimittelrichtlinien. Tacrolimus zur topischen Behandlung.
Dtsch Ärztebl.
2004;
101
A529-A531
-
25
Harper J I, Ahmed I, Barclay G. et al .
Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy.
Brit J Dermatol.
2000;
142
52-58
-
26
Grundmann-Kollmann M, Kaufmann R, Zollner T M.
Treatment of atopic dermatitis with mycophenolate mofetil.
Br J Dermatol.
2001;
145
351-352
Prof. Dr. med. Peter H. Höger
Katholisches Kinderkrankenhaus Wilhelmstift
Liliencronstraße 130
22149 Hamburg
Phone: 040/67377-202
Fax: 040/67377-293
Email: hoeger@kkh-wilhelmstift.de
